The DOI matches its Crossref record; 654 of the 654 references it cites were found in a registry or an index.
Inhibitors of Protein Methyltransferases and Demethylases
Open accessAbstract
Post-translational modifications of histones by protein methyltransferases (PMTs) and histone demethylases (KDMs) play an important role in the regulation of gene expression and transcription and are implicated in cancer and many other diseases. Many of these enzymes also target various nonhistone proteins impacting numerous crucial biological pathways. Given their key biological functions and implications in human diseases, there has been a growing interest in assessing these enzymes as potential therapeutic targets. Consequently, discovering and developing inhibitors of these enzymes has become a very active and fast-growing research area over the past decade. In this review, we cover the discovery, characterization, and biological application of inhibitors of PMTs and KDMs with emphasis on key advancements in the field. We also discuss challenges, opportunities, and future directions in this emerging, exciting research field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 654
Tang, J., Gary, J. D., Clarke, S., & Herschman, H. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16935 · Cited by 313
Bitoun, E., Oliver, P. L., & Davies, K. E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl444 · Cited by 312
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Chang, Y., Zhang, X., Horton, J. R., Upadhyay, A. K., Spannhoff, A., Liu, J., Snyder, J. P., Bedford, M. T., & Cheng, X. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1560 · Cited by 308
trans-2-Phenylcyclopropylamine Is a Mechanism-Based Inactivator of the Histone Demethylase LSD1
Schmidt, D. M. Z., & McCafferty, D. G. (2007) · Biochemistry · doi:10.1021/bi0618621 · Cited by 307
Histone methyltransferases in cancer
Albert, M., & Helin, K. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.10.007 · Cited by 306
PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation
Hyllus, D., Stein, C., Schnabel, K., Schiltz, E., Imhof, A., Dou, Y., Hsieh, J., & Bauer, U.-M. (2007) · Genes & Development · doi:10.1101/gad.447007 · Cited by 306
Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia
Cao, F., Townsend, E. C., Karatas, H., Xu, J., Li, L., Lee, S., Liu, L., Chen, Y., Ouillette, P., Zhu, J., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.001 · Cited by 301
Velichutina, I., Shaknovich, R., Geng, H., Johnson, N. A., Gascoyne, R. D., Melnick, A. M., & Elemento, O. (2010) · Blood · doi:10.1182/blood-2010-04-280149 · Cited by 299
A core–BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes
Hakimi, M.-A., Bochar, D. A., Chenoweth, J., Lane, W. S., Mandel, G., & Shiekhattar, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112008599 · Cited by 298
The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15Ink4b
He, J., Kallin, E. M., Tsukada, Y.-I., & Zhang, Y. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1499 · Cited by 295
Huang, Y., Greene, E., Murray Stewart, T., Goodwin, A. C., Baylin, S. B., Woster, P. M., & Casero, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700720104 · Cited by 292
Protein arginine-methyltransferase-dependent oncogenesis
Cheung, N., Chan, L. C., Thompson, A., Cleary, M. L., & So, C. W. E. (2007) · Nature Cell Biology · doi:10.1038/ncb1642 · Cited by 291
Crystal structure of human histone lysine-specific demethylase 1 (LSD1)
Chen, Y., Yang, Y., Wang, F., Wan, K., Yamane, K., Zhang, Y., & Lei, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606381103 · Cited by 291
Luo, Y., Arita, K., Bhatia, M., Knuckley, B., Lee, Y.-H., Stallcup, M. R., Sato, M., & Thompson, P. R. (2006) · Biochemistry · doi:10.1021/bi061180d · Cited by 290
Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase
Subramanian, K., Jia, D., Kapoor-Vazirani, P., Powell, D. R., Collins, R. E., Sharma, D., Peng, J., Cheng, X., & Vertino, P. M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.022 · Cited by 290
Fontebasso, A. M., Schwartzentruber, J., Khuong-Quang, D.-A., Liu, X.-Y., Sturm, D., Korshunov, A., Jones, D. T. W., Witt, H., Kool, M., Albrecht, S., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1095-8 · Cited by 290
A Role for Repressive Histone Methylation in Cocaine-Induced Vulnerability to Stress
Covington, H. E., Maze, I., Sun, H., Bomze, H. M., DeMaio, K. D., Wu, E. Y., Dietz, D. M., Lobo, M. K., Ghose, S., Mouzon, E., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.007 · Cited by 289
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
Eram, M. S., Shen, Y., Szewczyk, M. M., Wu, H., Senisterra, G., Li, F., Butler, K. V., Kaniskan, H. Ü., Speed, B. A., dela Seña, C., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00839 · Cited by 289
Self-citationYadav, N., Lee, J., Kim, J., Shen, J., Hu, M. C.-T., Aldaz, C. M., & Bedford, M. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232272100 · Cited by 287
JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes
Frescas, D., Guardavaccaro, D., Bassermann, F., Koyama-Nasu, R., & Pagano, M. (2007) · Nature · doi:10.1038/nature06255 · Cited by 284
Binda, C., Valente, S., Romanenghi, M., Pilotto, S., Cirilli, R., Karytinos, A., Ciossani, G., Botrugno, O. A., Forneris, F., Tardugno, M., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja101557k · Cited by 284
Cooperative Epigenetic Modulation by Cancer Amplicon Genes
Rui, L., Emre, N. C. T., Kruhlak, M. J., Chung, H.-J., Steidl, C., Slack, G., Wright, G. W., Lenz, G., Ngo, V. N., Shaffer, A. L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.013 · Cited by 283
Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
Pal, S., Baiocchi, R. A., Byrd, J. C., Grever, M. R., Jacob, S. T., & Sif, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601794 · Cited by 282
Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors
Yu, W., Chory, E. J., Wernimont, A. K., Tempel, W., Scopton, A., Federation, A., Marineau, J. J., Qi, J., Barsyte-Lovejoy, D., Yi, J., et al. (2012) · Nature Communications · doi:10.1038/ncomms2304 · Cited by 281
Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes
Nekrasov, M., Klymenko, T., Fraterman, S., Papp, B., Oktaba, K., Köcher, T., Cohen, A., Stunnenberg, H. G., Wilm, M., & Müller, J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601837 · Cited by 280
Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65
Lu, T., Jackson, M. W., Wang, B., Yang, M., Chance, M. R., Miyagi, M., Gudkov, A. V., & Stark, G. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912493107 · Cited by 280
DOT1L, the H3K79 methyltransferase, is required for MLL-AF9–mediated leukemogenesis
Nguyen, A. T., Taranova, O., He, J., & Zhang, Y. (2011) · Blood · doi:10.1182/blood-2011-02-334359 · Cited by 275
Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung Cancer
Lv, T., Yuan, D., Miao, X., Lv, Y., Zhan, P., Shen, X., & Song, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035065 · Cited by 273
A Novel Mammalian Flavin-dependent Histone Demethylase
Karytinos, A., Forneris, F., Profumo, A., Ciossani, G., Battaglioli, E., Binda, C., & Mattevi, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003087 · Cited by 273
Enhanced SMYD3 expression is essential for the growth of breast cancer cells
Hamamoto, R., Silva, F. P., Tsuge, M., Nishidate, T., Katagiri, T., Nakamura, Y., & Furukawa, Y. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00146.x · Cited by 268
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP
Liu, F., Barsyte-Lovejoy, D., Li, F., Xiong, Y., Korboukh, V., Huang, X.-P., Allali-Hassani, A., Janzen, W. P., Roth, B. L., Frye, S. V., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401480r · Cited by 268
Self-citationCloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product
Defeo-Jones, D., Huang, P. S., Jones, R. E., Haskell, K. M., Vuocolo, G. A., Hanobik, M. G., Huber, H. E., & Oliff, A. (1991) · Nature · doi:10.1038/352251a0 · Cited by 263
Structural origins of the selectivity of the trifunctional oxygenase clavaminic acid synthase.
Harlos, K., Schofield, C. J., Zhang, Z., Ren, J., STAMMERS, D. K., & Baldwin, J. E. (2000) · Nature Structural Biology · doi:10.1038/72398 · Cited by 260
In Vivo Residue-specific Histone Methylation Dynamics
Zee, B. M., Levin, R. S., Xu, B., LeRoy, G., Wingreen, N. S., & Garcia, B. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063784 · Cited by 260
Wang, L., Pal, S., & Sif, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00923-08 · Cited by 259
Kleefstra, T., van Zelst-Stams, W. A., Nillesen, W. M., Cormier-Daire, V, Houge, G., Foulds, N., van Dooren, M., Willemsen, M. H., Pfundt, R., Turner, A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062950 · Cited by 252
Human Histone Demethylase LSD1 Reads the Histone Code
Forneris, F., Binda, C., Vanoni, M. A., Battaglioli, E., & Mattevi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509549200 · Cited by 251
Radical Ideas about Monoamine Oxidase
Silverman, R. B. (1995) · Accounts of Chemical Research · doi:10.1021/ar00056a003 · Cited by 251
Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases
Rose, N. R., Ng, S. S., Mecinović, J., Liénard, B. M. R., Bello, S. H., Sun, Z., McDonough, M. A., Oppermann, U., & Schofield, C. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800936s · Cited by 250
Structure of the Neurospora SET Domain Protein DIM-5, a Histone H3 Lysine Methyltransferase
Zhang, X., Tamaru, H., Khan, S. I., Horton, J. R., Keefe, L. J., Selker, E. U., & Cheng, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00999-6 · Cited by 249
Imai, K., Togami, H., & Okamoto, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103531 · Cited by 248
Identification of functional cooperative mutations of SETD2 in human acute leukemia
Zhu, X., He, F., Zeng, H., Ling, S., Chen, A., Wang, Y., Yan, X., Wei, W., Pang, Y., Cheng, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.2894 · Cited by 247
DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity
Dong, K. B., Maksakova, I. A., Mohn, F., Leung, D., Appanah, R., Lee, S., Yang, H. W., Lam, L. L., Mager, D. L., Schübeler, D., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.193 · Cited by 242
Zurita-Lopez, C. I., Sandberg, T., Kelly, R., & Clarke, S. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336271 · Cited by 242
Structural basis for activity regulation of MLL family methyltransferases
Li, Y., Han, J., Zhang, Y., Cao, F., Liu, Z., Li, S., Wu, J., Hu, C., Wang, Y., Shuai, J., et al. (2016) · Nature · doi:10.1038/nature16952 · Cited by 242
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
Benevolenskaya, E. V., Murray, H. L., Branton, P., Young, R. A., & Kaelin, W. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.012 · Cited by 241
Splicing enhances recruitment of methyltransferase HYPB/Setd2 and methylation of histone H3 Lys36
de Almeida, S. F., Grosso, A. R., Koch, F., Fenouil, R., Carvalho, S., Andrade, J., Levezinho, H., Gut, M., Eick, D., Gut, I., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2123 · Cited by 241
Najbauer, J., Johnson, B. A., Young, A. L., & Aswad, D. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82227-x · Cited by 240
Cho, H.-S., Suzuki, T., Dohmae, N., Hayami, S., Unoki, M., Yoshimatsu, M., Toyokawa, G., Takawa, M., Chen, T., Kurash, J. K., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2446 · Cited by 240
Duns, G., van den Berg, E., van Duivenbode, I., Osinga, J., Hollema, H., Hofstra, R. M. W., & Kok, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0120 · Cited by 239
Histone demethylases in chromatin biology and beyond
Dimitrova, E., Turberfield, A. H., & Klose, R. J. (2015) · EMBO reports · doi:10.15252/embr.201541113 · Cited by 238
PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB
Wei, H., Wang, B., Miyagi, M., She, Y., Gopalan, B., Huang, D.-B., Ghosh, G., Stark, G. R., & Lu, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311784110 · Cited by 237
Negative regulation of transcription by the type II arginine methyltransferase PRMT5
Fabbrizio, E., Messaoudi, S. E., Polanowska, J., Paul, C., Cook, J. R., Lee, J., Nègre, V., Rousset, M., Pestka, S., Le Cam, A., et al. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf136 · Cited by 237
Regulation of NF-κB activity through lysine monomethylation of p65
Ea, C.-K., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910439106 · Cited by 236
Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases
Walport, L. J., Hopkinson, R. J., Chowdhury, R., Schiller, R., Ge, W., Kawamura, A., & Schofield, C. J. (2016) · Nature Communications · doi:10.1038/ncomms11974 · Cited by 236
PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145
Yang, Y., Hadjikyriacou, A., Xia, Z., Gayatri, S., Kim, D., Zurita-Lopez, C., Kelly, R., Guo, A., Li, W., Clarke, S. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms7428 · Cited by 235
Structural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition
Forneris, F., Binda, C., Adamo, A., Battaglioli, E., & Mattevi, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700100200 · Cited by 235
Kondo, Y., Shen, L., Ahmed, S., Boumber, Y., Sekido, Y., Haddad, B. R., & Issa, J.-P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002037 · Cited by 234
Yang, M., Culhane, J. C., Szewczuk, L. M., Jalili, P., Ball, H. L., Machius, M., Cole, P. A., & Yu, H. (2007) · Biochemistry · doi:10.1021/bi700664y · Cited by 234
Lipopolysaccharide-induced Methylation of HuR, an mRNA-stabilizing Protein, by CARM1
Li, H., Park, S., Kilburn, B., Jelinek, M. A., Henschen-Edman, A., Aswad, D. W., Stallcup, M. R., & Laird-Offringa, I. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206187200 · Cited by 233
A Novel WD Repeat Protein Component of the Methylosome Binds Sm Proteins
Friesen, W. J., Wyce, A., Paushkin, S., Abel, L., Rappsilber, J., Mann, M., & Dreyfuss, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109984200 · Cited by 233
PABP1 identified as an arginine methyltransferase substrate using high‐density protein arrays
Lee, J., & Bedford, M. T. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf052 · Cited by 230
Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs
Dhar, S., Vemulapalli, V., Patananan, A. N., Huang, G. L., Di Lorenzo, A., Richard, S., Comb, M. J., Guo, A., Clarke, S. G., & Bedford, M. T. (2013) · Scientific Reports · doi:10.1038/srep01311 · Cited by 228
Inhibition of demethylases by GSK-J1/J4
Heinemann, B., Nielsen, J. M., Hudlebusch, H. R., Lees, M. J., Larsen, D. V., Boesen, T., Labelle, M., Gerlach, L.-O., Birk, P., & Helin, K. (2014) · Nature · doi:10.1038/nature13688 · Cited by 228
Yang, Z., Imoto, I., Fukuda, Y., Pimkhaokham, A., Shimada, Y., Imamura, M., Sugano, S., Nakamura, Y., & Inazawa, J. (2000) · PubMed · Cited by 228
Southall, S. M., Wong, P.-S., Odho, Z., Roe, S. M., & Wilson, J. R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.029 · Cited by 228
Wang, J., Lu, F., Ren, Q., Sun, H., Xu, Z., Lan, R., Liu, Y., Ward, D., Quan, J., Ye, T., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0896 · Cited by 228
Xu, B., On, D. M., Ma, A., Parton, T., Konze, K. D., Pattenden, S. G., Allison, D. F., Cai, L., Rockowitz, S., Liu, S., et al. (2015) · Blood · doi:10.1182/blood-2014-06-581082 · Cited by 227
Self-citationThe EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
He, Y., Selvaraju, S., Curtin, M. L., Jakob, C. G., Zhu, H., Comess, K. M., Shaw, B., The, J., Lima-Fernandes, E., Szewczyk, M. M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2306 · Cited by 224
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Neff, T., Sinha, A. U., Kluk, M. J., Zhu, N., Khattab, M. H., Stein, L., Xie, H., Orkin, S. H., & Armstrong, S. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202258109 · Cited by 224
King, O. N. F., Li, X. S., Sakurai, M., Kawamura, A., Rose, N. R., Ng, S. S., Quinn, A. M., Rai, G., Mott, B. T., Beswick, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015535 · Cited by 223
Methylation of the Retinoblastoma Tumor Suppressor by SMYD2
Saddic, L. A., West, L. E., Aslanian, A., Yates, J. R., Rubin, S. M., Gozani, O., & Sage, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137612 · Cited by 223
Arginine methyltransferase CARM1 is a promoter‐specific regulator of NF‐κB‐dependent gene expression
Covic, M., Hassa, P. O., Saccani, S., Buerki, C., Meier, N. I., Lombardi, C., Imhof, R., Bedford, M. T., Natoli, G., & Hottiger, M. O. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600500 · Cited by 223
Hakimi, M.-A., Dong, Y., Lane, W. S., Speicher, D. W., & Shiekhattar, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208992200 · Cited by 221
Human UTY(KDM6C) Is a Male-specific Nϵ-Methyl Lysyl Demethylase
Walport, L. J., Hopkinson, R. J., Vollmar, M., Madden, S. K., Gileadi, C., Oppermann, U., Schofield, C. J., & Johansson, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555052 · Cited by 219
Zheng, Y.-C., Duan, Y.-C., Ma, J.-L., Xu, R.-M., Zi, X., Lv, W.-L., Wang, M.-M., Ye, X.-W., Zhu, S., Mobley, D., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401002r · Cited by 218
Arginine methylation controls growth regulation by E2F‐1
Cho, E., Zheng, S., Munro, S., Liu, G., Carr, S. M., Moehlenbrink, J., Lu, Y., Stimson, L., Khan, O., Konietzny, R., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.17 · Cited by 216
Ketel, C. S., Andersen, E. F., Vargas, M. L., Suh, J., Strome, S., & Simon, J. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.6857-6868.2005 · Cited by 216
Vaswani, R. G., Gehling, V. S., Dakin, L. A., Cook, A. S., Nasveschuk, C. G., Duplessis, M., Iyer, P., Balasubramanian, S., Zhao, F., Good, A. C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01315 · Cited by 216
Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D
Shin, S., & Janknecht, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.179 · Cited by 213
Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate
Laumonnier, F., Holbert, S., Ronce, N., Faravelli, F., Lenzner, S., Schwartz, C. E., Lespinasse, J., Van Esch, H., Lacombe, D., Goizet, C., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.029439 · Cited by 213
Souroullas, G. P., Jeck, W. R., Parker, J. S., Simon, J. M., Liu, J.-Y., Paulk, J., Xiong, J., Clark, K. S., Fedoriw, Y., Qi, J., et al. (2016) · Nature Medicine · doi:10.1038/nm.4092 · Cited by 212
Black, J. C., Manning, A. L., Van Rechem, C., Kim, J., Ladd, B., Cho, J., Pineda, C. M., Murphy, N., Daniels, D. L., Montagna, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.051 · Cited by 212
Histone Lysine Methyltransferase SETD8 Promotes Carcinogenesis by Deregulating PCNA Expression
Takawa, M., Cho, H.-S., Hayami, S., Toyokawa, G., Kogure, M., Yamane, Y., Iwai, Y., Maejima, K., Ueda, K., Masuda, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3701 · Cited by 211
Kauffman, E. C., Robinson, B. D., Downes, M. J., Powell, L. G., Lee, M. M., Scherr, D. S., Gudas, L. J., & Mongan, N. P. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20758 · Cited by 210
He, J., Nguyen, A. T., & Zhang, Y. (2011) · Blood · doi:10.1182/blood-2010-10-312736 · Cited by 207
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
Yamamoto, S., Wu, Z., Russnes, H. G., Takagi, S., Peluffo, G., Vaske, C., Zhao, X., Moen Vollan, H. K., Maruyama, R., Ekram, M. B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.024 · Cited by 207
Hayami, S., Yoshimatsu, M., Veerakumarasivam, A., Unoki, M., Iwai, Y., Tsunoda, T., Field, H. I., Kelly, J. D., Neal, D. E., Yamaue, H., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-59 · Cited by 207
Liu, F., Chen, X., Allali-Hassani, A., Quinn, A. M., Wigle, T. J., Wasney, G. A., Dong, A., Senisterra, G., Chau, I., Siarheyeva, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100478y · Cited by 205
Self-citationHong, H., Kao, C., Jeng, M., Eble, J. N., Koch, M. O., Gardner, T. A., Zhang, S., Li, L., Pan, C., Hu, Z., et al. (2004) · Cancer · doi:10.1002/cncr.20327 · Cited by 204
Sorna, V., Theisen, E. R., Stephens, B., Warner, S. L., Bearss, D. J., Vankayalapati, H., & Sharma, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400870h · Cited by 204
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Ferguson, A. D., Larsen, N. A., Howard, T., Pollard, H., Green, I., Grande, C., Cheung, T., Garcia-Arenas, R., Cowen, S., Wu, J., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.011 · Cited by 203
Liu, G., Bollig-Fischer, A., Kreike, B., van de Vijver, M. J., Abrams, J., Ethier, S. P., & Yang, Z. Q. (2009) · Oncogene · doi:10.1038/onc.2009.297 · Cited by 202
High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction
Karatas, H., Townsend, E. C., Cao, F., Chen, Y., Bernard, D., Liu, L., Lei, M., Dou, Y., & Wang, S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja306028q · Cited by 202
Arginine Methylation of the Histone H3 Tail Impedes Effector Binding
Iberg, A. N., Espejo, A., Cheng, D., Kim, D., Michaud-Levesque, J., Richard, S., & Bedford, M. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c700192200 · Cited by 201
Control of CBP co-activating activity by arginine methylation
Chevillard-Briet, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf548 · Cited by 200
Trojer, P., Zhang, J., Yonezawa, M., Schmidt, A., Zheng, H., Jenuwein, T., & Reinberg, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807818200 · Cited by 199
Methylation of Tat by PRMT6 Regulates Human Immunodeficiency Virus Type 1 Gene Expression
Boulanger, M.-C., Liang, C., Russell, R. S., Lin, R., Bedford, M. T., Wainberg, M. A., & Richard, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.124-131.2005 · Cited by 199
Abu-Farha, M., Lambert, J.-P., Al-Madhoun, A. S., Elisma, F., Skerjanc, I. S., & Figeys, D. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700271-mcp200 · Cited by 198
Structural analysis of human KDM5B guides histone demethylase inhibitor development
Johansson, C., Velupillai, S., Tumber, A., Szykowska, A., Hookway, E. S., Nowak, R. P., Strain-Damerell, C., Gileadi, C., Philpott, M., Burgess-Brown, N., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2087 · Cited by 197
Distinct binding modes specify the recognition of methylated histones H3K4 and H4K20 by JMJD2A-tudor
Lee, J., Thompson, J. R., Botuyan, M. V., & Mer, G. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1326 · Cited by 195
Hsia, D. A., Tepper, C. G., Pochampalli, M. R., Hsia, E. Y. C., Izumiya, C., Huerta, S. B., Wright, M. E., Chen, H.-W., Kung, H.-J., & Izumiya, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000401107 · Cited by 195
Structural basis for molecular recognition and presentation of histone H3 By WDR5
Schuetz, A., Allali‐Hassani, A., Martín, F., Loppnau, P., Vedadi, M., Bochkarev, A., Plotnikov, A. N., Arrowsmith, C. H., & Min, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601316 · Cited by 194
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
Sweis, R. F., Pliushchev, M., Brown, P. J., Guo, J., Li, F., Maag, D., Petros, A. M., Soni, N. B., Tse, C., Vedadi, M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400496h · Cited by 193
Arginine Methylation Regulates DNA Polymerase β
El-Andaloussi, N., Valovka, T., Toueille, M., Steinacher, R., Focke, F., Gehrig, P., Covic, M., Hassa, P. O., Schär, P., Hübscher, U., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.013 · Cited by 193
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Wagner, K. W., Alam, H., Dhar, S. S., Giri, U., Li, N., Wei, Y., Giri, D., Cascone, T., Kim, J.-H., Ye, Y., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68642 · Cited by 193
AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2
Kim, H., Kang, K., & Kim, J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp149 · Cited by 192
Targeting histone lysine demethylases — Progress, challenges, and the future
Thinnes, C. C., England, K. S., Kawamura, A., Chowdhury, R., Schofield, C. J., & Hopkinson, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.009 · Cited by 192
Protein arginine methylation of non-histone proteins and its role in diseases
Wei, H., Mundade, R., Lange, K., & Lu, T. (2014) · Cell Cycle · doi:10.4161/cc.27353 · Cited by 190
Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
Ueda, R., Suzuki, T., Mino, K., Tsumoto, H., Nakagawa, H., Hasegawa, M., Sasaki, R., Mizukami, T., & Miyata, N. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907055q · Cited by 189
Goulet, I., Gauvin, G., Boisvenue, S., & Côté, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704349200 · Cited by 189
Wei, T. W., Juan, C., Hisa, J., Su, L., Lee, Y. G., Chou, H., Chen, J. M., Wu, Y., Chiu, S., Hsu, C., et al. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02367.x · Cited by 189
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
Zheng, Y., Ma, J., Wang, Z., Li, J., Jiang, B., Zhou, W., Shi, X., Wang, X., Zhao, W., & Liu, H. (2015) · Medicinal Research Reviews · doi:10.1002/med.21350 · Cited by 186
Targeting histone lysine methylation in cancer
McGrath, J., & Trojer, P. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.002 · Cited by 186
Recent Progress in Histone Demethylase Inhibitors
McAllister, T. E., England, K. S., Hopkinson, R. J., Brennan, P. E., Kawamura, A., & Schofield, C. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01758 · Cited by 186
( R )-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells
Barsyte-Lovejoy, D., Li, F., Oudhoff, M. J., Tatlock, J. H., Dong, A., Zeng, H., Wu, H., Freeman, S. A., Schapira, M., Senisterra, G. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407358111 · Cited by 185
Walker, E., Chang, W. Y., Hunkapiller, J., Cagney, G., Garcha, K., Torchia, J., Krogan, N. J., Reiter, J. F., & Stanford, W. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2009.12.014 · Cited by 183
Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling
Hu, M., Sun, X.-J., Zhang, Y.-L., Kuang, Y., Hu, C.-Q., Wu, W.-L., Shen, S.-H., Du, T.-T., Li, H., He, F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915033107 · Cited by 182
Yang, J., Jubb, A. M., Pike, L., Buffa, F. M., Turley, H., Baban, D., Leek, R., Gatter, K. C., Ragoussis, J., & Harris, A. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0413 · Cited by 182
Yuan, Y., Wang, Q., Paulk, J., Kubicek, S., Kemp, M. M., Adams, D. J., Shamji, A. F., Wagner, B. K., & Schreiber, S. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300139y · Cited by 181
KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs
Tzatsos, A., Paskaleva, P., Ferrari, F., Deshpande, V., Stoykova, S., Contino, G., Wong, K.-K., Lan, F., Trojer, P., Park, P. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64535 · Cited by 178
Structural basis of histone demethylation by LSD1 revealed by suicide inactivation
Yang, M., Culhane, J. C., Szewczuk, L. M., Gocke, C. B., Brautigam, C. A., Tomchick, D. R., Machius, M., Cole, P. A., & Yu, H. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1255 · Cited by 178
Pereira, F., Barbáchano, A., Silva, J., Bonilla, F., Campbell, M. J., Muñoz, A., & Larriba, M. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr399 · Cited by 177
Boisvert, F., Rhie, A., Richard, S., & Doherty, A. J. (2005) · Cell Cycle · doi:10.4161/cc.4.12.2250 · Cited by 177
Brooun, A., Gajiwala, K. S., Deng, Y., Liu, W., Bolaños, B., Bingham, P., He, Y.-A., Diehl, W. C., Grable, N., Kung, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms11384 · Cited by 177
Mimasu, S., Umezawa, N., Sato, S., Higuchi, T., Umehara, T., & Yokoyama, S. (2010) · Biochemistry · doi:10.1021/bi100299r · Cited by 175
Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
Deshpande, A. J., Chen, L., Fazio, M., Sinha, A. U., Bernt, K. M., Banka, D., Dias, S., Chang, J., Olhava, E. J., Daigle, S. R., et al. (2013) · Blood · doi:10.1182/blood-2012-11-465120 · Cited by 174
Komatsu, S., Imoto, I., Tsuda, H., Kozaki, K.-I., Muramatsu, T., Shimada, Y., Aiko, S., Yoshizumi, Y., Ichikawa, D., Otsuji, E., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp116 · Cited by 173
Nonprocessive methylation by Dot1 leads to functional redundancy of histone H3K79 methylation states
Frederiks, F., Tzouros, M., Oudgenoeg, G., van Welsem, T., Fornerod, M., Krijgsveld, J., & van Leeuwen, F. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1432 · Cited by 172
Zeng, J., Ge, Z., Wang, L., Li, Q., Wang, N., Björkholm, M., Jia, J., & Xu, D. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.004 · Cited by 172
Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide
Patel, A., Dharmarajan, V., & Cosgrove, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800164200 · Cited by 171
Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation
Van Aller, G. S., Reynoird, N., Barbash, O., Huddleston, M., Liu, S., Zmoos, A.-F., McDevitt, P., Sinnamon, R., Le, B., Mas, G., et al. (2012) · Epigenetics · doi:10.4161/epi.19506 · Cited by 170
Bachand, F., & Silver, P. A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600265 · Cited by 170
The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation
Qiao, Q., Li, Y., Chen, Z., Wang, M., Reinberg, D., & Xu, R.-M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204115 · Cited by 170
Tarighat, S. S., Santhanam, R., Frankhouser, D., Radomska, H. S., Lai, H., Anghelina, M., Wang, H., Huang, X., Alinari, L., Walker, A., et al. (2016) · Leukemia · doi:10.1038/leu.2015.308 · Cited by 169
Biswas, D., Milne, T. A., Basrur, V., Kim, J., Elenitoba-Johnson, K. S. J., Allis, C. D., & Roeder, R. G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111498108 · Cited by 168
The Roles of Jumonji-Type Oxygenases in Human Disease
Johansson, C., Tumber, A., Che, K., Cain, P., Nowak, R., Gileadi, C., & Oppermann, U. (2014) · Epigenomics · doi:10.2217/epi.13.79 · Cited by 166
Kim, Y., Lee, H.-M., Xiong, Y., Sciaky, N., Hulbert, S. W., Cao, X., Everitt, J. I., Jin, J. J., Roth, B. L., & Jiang, Y. (2016) · Nature Medicine · doi:10.1038/nm.4257 · Cited by 166
Self-citationHigh-Resolution Genome-wide Mapping of the Primary Structure of Chromatin
Zhang, Z., & Pugh, B. F. (2011) · Cell · doi:10.1016/j.cell.2011.01.003 · Cited by 165
Ma, L., Zheng, Y., Wang, S., Wang, B., Wang, Z.-R., Pang, L.-P., Zhang, M., Wang, J.-W., Ding, L., Li, J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00037 · Cited by 165
Hopkinson, R. J., Tumber, A., Yapp, C., Chowdhury, R., Aik, W., Che, K. H., Li, X. S., Kristensen, J. B. L., King, O. N. F., Chan, M. C., et al. (2013) · Chemical Science · doi:10.1039/c3sc51122g · Cited by 164
Feng, Q., Yi, P., Wong, J., & O'Malley, B. W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00568-06 · Cited by 164
Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines
Liu, F., Baršytė-Lovejoy, D., Allali‐Hassani, A., He, Y., Herold, J. M., Chen, X., Yates, C. M., Frye, S. V., Brown, P. J., Huang, J. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200903z · Cited by 163
Self-citationAlinari, L., Mahasenan, K. V., Yan, F., Karkhanis, V. A., Chung, J.-H., Smith, E. M., Quinion, C. D., Smith, P. L., Kim, L., Patton, J. T., et al. (2015) · Blood · doi:10.1182/blood-2014-12-619783 · Cited by 163
Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation
Zhang, X., Tanaka, K., Yan, J., Li, J., Peng, D., Jiang, Y., Yang, Z., Barton, M. C., Wen, H., & Shi, X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307959110 · Cited by 163
Guderian, G., Peter, C., Wiesner, J., Sickmann, A., Schulze-Osthoff, K., Fischer, U., & Grimmler, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148486 · Cited by 162
Bao, X., Zhao, S., Liu, T., Liu, Y., Liu, Y., & Yang, X. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413475452 · Cited by 162
Hamada, S., Suzuki, T., Mino, K., Koseki, K., Oehme, F., Flamme, I., Ozasa, H., Itoh, Y., Ogasawara, D., Komaarashi, H., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1003655 · Cited by 162
Garapaty, S., Nasveschuk, C. G., Gagnon, A., Chan, E. Y., Sandy, P., Busby, J., Balasubramanian, S., Campbell, R., Zhao, F., Bergeron, L., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.013 · Cited by 161
Sarris, M. E., Moulos, P., Haroniti, A., Giakountis, A., & Talianidis, I. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.01.013 · Cited by 161
Yao, Y., Chen, P., Diao, J., Cheng, G., Deng, L., Anglin, J. L., Prasad, B. V. V., & Song, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206312b · Cited by 160
Wen, H., Li, J., Song, T., Lu, M., Kan, P., Lee, M. G., Sha, B., & Shi, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.097667 · Cited by 160
Sinha, K. M., Yasuda, H., Coombes, M. M., Dent, S. Y. R., & de Crombrugghe, B. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.332 · Cited by 160
Watanabe, H., Soejima, K., Yasuda, H., Kawada, I., Nakachi, I., Yoda, S., Naoki, K., & Ishizaka, A. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-15 · Cited by 160
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Duncan, K. W., Rioux, N., Boriack-Sjodin, P. A., Munchhof, M. J., Reiter, L. A., Majer, C. R., Jin, L., Johnston, L. D., Chan-Penebre, E., Kuplast, K. G., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00380 · Cited by 160
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
Senisterra, G., Wu, H., Allali-Hassani, A., Wasney, G. A., Barsyte-Lovejoy, D., Dombrovski, L., Dong, A., Nguyen, K. T., Smil, D., Bolshan, Y., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121280 · Cited by 159
Powers, M. A., Fay, M. M., Factor, R. E., Welm, A. L., & Ullman, K. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0458 · Cited by 159
Smith, J. A., White, E. A., Sowa, M. E., Powell, M. L. C., Ottinger, M., Harper, J. W., & Howley, P. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914818107 · Cited by 159
Plant Growth Regulator Daminozide Is a Selective Inhibitor of Human KDM2/7 Histone Demethylases
Rose, N. R., Woon, E. C. Y., Tumber, A., Walport, L. J., Chowdhury, R., Li, X. S., King, O. N. F., Lejeune, C., Ng, S. S., Krojer, T., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300677j · Cited by 159
KDM7 is a dual demethylase for histone H3 Lys 9 and Lys 27 and functions in brain development
Tsukada, Y.-I., Ishitani, T., & Nakayama, K. I. (2010) · Genes & Development · doi:10.1101/gad.1864410 · Cited by 158
G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitmentPreprint
Chen, X., Skutt-Kakaria, K., Davison, J., Ou, Y.-L., Choi, E., Malik, P., Loeb, K. R., Wood, B. L., Georges, G. E., Torok‐Storb, B., et al. (2012) · Genes & Development · doi:10.1101/gad.200329.112 · Cited by 158
Sinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2
Zheng, W., Ibáñez, G., Wu, H., Blum, G., Zeng, H., Dong, A., Li, F., Hajian, T., Allali‐Hassani, A., Amaya, M. F., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307060p · Cited by 157
Niu, X., Zhang, T., Liao, L., Zhou, L., Lindner, D. J., Zhou, M., Rini, B. I., Yan, Q., & Yang, H. (2011) · Oncogene · doi:10.1038/onc.2011.266 · Cited by 157
Zhao, W., Li, Q., Ayers, S. D., Gu, Y., Shi, Z. Q., Zhu, Q., Chen, Y., Wang, H. Y., & Wang, R. (2013) · Cell · doi:10.1016/j.cell.2013.02.006 · Cited by 156
Luo, X., Liu, Y., Kubicek, S., Myllyharju, J., Tumber, A., Ng, S. S., Che, K. H., Podoll, J. D., Heightman, T. D., Oppermann, U. C. T., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201597b · Cited by 155
Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans
Ge, W., Wolf, A., Feng, T., Ho, C.-H., Sekirnik, R., Zayer, A., Granatino, N., Cockman, M. E., Loenarz, C., Loik, N. D., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1093 · Cited by 154
Culhane, J. C., Wang, D., Yen, P. M., & Cole, P. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909996p · Cited by 154
Oyer, J. A., Huang, X., Zheng, Y., Shim, J. Y., Ezponda, T., Carpenter, Z., Allegretta, M., Okot-Kotber, C. I., Patel, J. P., Melnick, A. F., et al. (2013) · Leukemia · doi:10.1038/leu.2013.204 · Cited by 153
Anderton, J. A., Bose, S., Vockerodt, M., Vrzalikova, K., Wei, W., Kuo, M., Helin, K., Christensen, J. F., Rowe, M., Murray, P. G., et al. (2011) · Oncogene · doi:10.1038/onc.2010.579 · Cited by 152
Ren, J., Wang, Y., Liang, Y., Zhang, Y., Bao, S., & Xu, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103911 · Cited by 152
Bradley, W. D., Arora, S., Busby, J., Balasubramanian, S., Gehling, V. S., Nasveschuk, C. G., Vaswani, R. G., Yuan, C.-C., Hatton, C., Zhao, F., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.017 · Cited by 152
Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins
Gonsalvez, G. B., Tian, L., Ospina, J. K., Boisvert, F., Lamond, A. I., & Matera, A. G. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702147 · Cited by 151
PRMT7 Induces Epithelial-to-Mesenchymal Transition and Promotes Metastasis in Breast Cancer
Yao, R., Jiang, H., Ma, Y., Wang, L., Wang, L., Du, J., Hou, P., Gao, Y., Zhao, L., Wang, G., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0800 · Cited by 151
Majumder, S., Liu, Y., Ford, O. H., Mohler, J. L., & Whang, Y. E. (2006) · The Prostate · doi:10.1002/pros.20438 · Cited by 151
Allis, C. D., Bowen, J. K., Abraham, G. N., Glover, C. V. C., & Gorovsky, M. A. (1980) · Cell · doi:10.1016/0092-8674(80)90234-2 · Cited by 150
A Mechanism-Based Inactivator for Histone Demethylase LSD1
Culhane, J. C., Szewczuk, L. M., Liu, X., Da, G., Marmorstein, R., & Cole, P. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0602748 · Cited by 150
Gibaja, V, Shen, F., Harari, J., Korn, J., Ruddy, D., Saenz-Vash, V, Zhai, H., Rejtar, T., Paris, C. G., Yu, Z., et al. (2016) · Oncogene · doi:10.1038/onc.2015.114 · Cited by 149
Arginine Methylation-Dependent Reader-Writer Interplay Governs Growth Control by E2F-1
Zheng, S., Moehlenbrink, J., Lu, Y.-C., Zalmas, L., Sagum, C. A., Carr, S. M., McGouran, J. F., Alexander, L. T., Fedorov, O., Munro, S., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.039 · Cited by 149
Target-Based Approach to Inhibitors of Histone Arginine Methyltransferases
Spannhoff, A., Heinke, R., Bauer, I., Trojer, P., Metzger, E., Gust, R., Schüle, R., Brosch, G., Sippl, W., & Jung, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061250e · Cited by 148
Kanıskan, H. Ü., Szewczyk, M. M., Yu, Z., Eram, M. S., Yang, X., Schmidt, K. T., Luo, X., Dai, M., He, F., Zang, I., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412154 · Cited by 148
Self-citationLSD1 and the chemistry of histone demethylation
Culhane, J. C., & Cole, P. A. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.07.014 · Cited by 147
Basavapathruni, A., Jin, L., Daigle, S. R., Majer, C. R., Therkelsen, C. A., Wigle, T. J., Kuntz, K. W., Chesworth, R., Pollock, R. M., Scott, M. P., et al. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12050 · Cited by 147
Smith, J. J., Rücknagel, K. P., Schierhorn, A., Tang, J., Németh, A., Linder, M., Herschman, H. R., & Wahle, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13229 · Cited by 146
Lysine Demethylases Inhibitors
Suzuki, T., & Miyata, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201048w · Cited by 146
Ho, M.-C., Wilczek, C., Bonanno, J. B., Li, X., Seznec, J., Matsui, T., Carter, L. G., Onikubo, T., Kumar, P. R., Chan, M. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057008 · Cited by 144
Oncogenic features of the JMJD2A histone demethylase in breast cancer
Berry, W. L., Shin, S., Lightfoot, S. A., & Janknecht, R. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1618 · Cited by 143
Lucio-Eterovic, A. K., Singh, M. M., Gardner, J. E., Veerappan, C. S., Rice, J. C., & Carpenter, P. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002653107 · Cited by 143
Ribosomal Protein rpS2 Is Hypomethylated in PRMT3-deficient Mice
Swiercz, R., Cheng, D., Kim, D., & Bedford, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609778200 · Cited by 143
Andreu-Pérez, P., Esteve‐Puig, R., de Torre‐Minguela, C., López‐Fauqued, M., Bech‐Serra, J. J., Tenbaum, S. P., García–Trevijano, E. R., Canals, F., Merlino, G. T., Avila, M. A., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001936 · Cited by 143
Role of histone modifications in defining chromatin structure and function
Gelato, K. A., & Fischle, W. (2008) · Biological Chemistry · doi:10.1515/bc.2008.048 · Cited by 140
Mould, D. P., McGonagle, A. E., Wiseman, D. H., Williams, E. L., & Jordan, A. M. (2014) · Medicinal Research Reviews · doi:10.1002/med.21334 · Cited by 140
Hudlebusch, H. R., Santoni‐Rugiu, E., Simon, R., Ralfkiaer, E. M., Holten‐Rossing, H., Johansen, J. V., Jørgensen, M., Sauter, G., & Helin, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1302 · Cited by 139
Dharmarajan, V., Lee, J., Patel, A. B., Skalnik, D. G., & Cosgrove, M. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364125 · Cited by 139
Gossage, L., Murtaza, M., Slatter, A. F., Lichtenstein, C. P., Warren, A. Y., Haynes, B., Marass, F., Roberts, I., Shanahan, S. J., Claas, A., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22116 · Cited by 137
SET7/9 mediated methylation of non-histone proteins in mammalian cells
Pradhan, S., Chin, H. G., Estève, P., & Jacobsen, S. E. (2009) · Epigenetics · doi:10.4161/epi.4.6.9450 · Cited by 137
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
Nguyen, H., Allali‐Hassani, A., Antonysamy, S., Chang, S. S., Chen, L. H., Curtis, C., Emtage, S., Li, F., Gheyi, T., Li, F., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.626861 · Cited by 137
(Bis)urea and (Bis)thiourea Inhibitors of Lysine-Specific Demethylase 1 as Epigenetic Modulators
Sharma, S. K., Wu, Y., Steinbergs, N., Crowley, M. L., Hanson, A. S., Casero, R. A., & Woster, P. M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100217a · Cited by 137
Selective Inhibitors of Protein Methyltransferases
Kanıskan, H. Ü., Konze, K. D., & Jin, J. J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501234a · Cited by 137
Self-citationCrystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å
Mimasu, S., Sengoku, T., Fukuzawa, S., Umehara, T., & Yokoyama, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.066 · Cited by 137
The PRMT1 gene expression pattern in colon cancer
Mathioudaki, K., Παπαδοκωστοπούλου, Α., Scorilas, A., Xynopoulos, D., Agnanti, N., & Talieri, M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604807 · Cited by 136
Cited by
Advancing targeted protein degradation for cancer therapy
Dale, B., Cheng, M., Park, K.-S., Kaniskan, H. Ü., Xiong, Y., & Jin, J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00365-x · Cited by 632
Self-citationLSD1/KDM1A inhibitors in clinical trials: advances and prospects
Fang, Y., Liao, G., & Yu, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0811-9 · Cited by 438
Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
Biswas, S., & Rao, C. M. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.021 · Cited by 389
Pathogenesis of allergic diseases and implications for therapeutic interventions
Wang, J., Zhou, Y., Zhang, H., Hu, L., Liu, J., Wang, L., Wang, T., Zhang, H., Cong, L., & Wang, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01344-4 · Cited by 376
Epigenetic modulation of antitumor immunity for improved cancer immunotherapy
Dai, E., Zhu, Z., Wahed, S., Qu, Z., Storkus, W. J., & Guo, Z. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01464-x · Cited by 328
Metadata
- Authors
- Kaniskan, H. Ü., Martini, M. L., & Jin, J.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-03-24
- Volume
- 118
- Issue
- 3
- Pages
- 989-1068
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2602027562
- Cited by
- 297
- References
- 654
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.